or Try an Advanced Search...

    Technical Analysis for BTAI - BioXcel Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.60 -4.13% -0.11
    BTAI closed down 8.75 percent on Wednesday, April 24, 2024, on 69 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    Earnings due: May 6
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BTAI trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish -4.13%
    Fell Below 50 DMA Bearish -4.13%
    Expansion Pivot Sell Setup Bearish Swing Setup -4.13%
    Upper Bollinger Band Touch Strength -4.13%
    Crossed Above 50 DMA Bullish -12.53%
    BB Squeeze Ended Range Expansion -12.53%
    Above Upper BB Strength -12.53%
    Up 3 Days in a Row Strength -12.53%
    Upper Bollinger Band Touch Strength -12.53%
    20 DMA Support Bullish -8.84%
    Older End-of-Day Signals for BTAI ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 2 hours ago
    Down 5% about 2 hours ago
    Down 3% about 3 hours ago
    Expansion Pivot Sell Entry about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BTAI Chart by TradingView
    Basic chart:

    Profile

    BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company which is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Artificial Intelligence Neuroscience Drug Development Cybernetics Computational Neuroscience

    Is BTAI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual Meeting
    Apr 22 BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential
    Apr 10 BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501 for Agitation Associated With Alzheimer’s Dementia
    Mar 25 BioXcel launches $25M direct offering of stock and warrants
    Mar 25 BioXcel Therapeutics Announces $25 Million Registered Direct Offering
    Mar 24 BioXcel Therapeutics Full Year 2023 Earnings: Revenues Disappoint
    Mar 15 BioXcel Therapeutics Announces European Patent Office’s Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine
    Mar 13 BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2023 Earnings Call Transcript
    Mar 13 Q4 2023 BioXcel Therapeutics Inc Earnings Call
    Mar 12 BioXcel Therapeutics, Inc. (BTAI) Q4 2023 Earnings Call Transcript
    See more BTAI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 29.56
    52 Week Low 1.91
    Average Volume 1,284,316
    200-Day Moving Average 3.99
    50-Day Moving Average 2.90
    20-Day Moving Average 2.73
    10-Day Moving Average 2.75
    Average True Range 0.22
    RSI (14) 47.37
    ADX 12.81
    +DI 26.16
    -DI 19.23
    Chandelier Exit (Long, 3 ATRs) 2.45
    Chandelier Exit (Short, 3 ATRs) 3.17
    Upper Bollinger Bands 2.96
    Lower Bollinger Band 2.50
    Percent B (%b) 0.47
    BandWidth 16.95
    MACD Line -0.03
    MACD Signal Line -0.05
    MACD Histogram 0.026
    Fundamentals Value
    Market Cap 82.33 Million
    Num Shares 30.4 Million
    EPS -7.36
    Price-to-Earnings (P/E) Ratio -0.37
    Price-to-Sales 92.61
    Price-to-Book 3.97
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.21
    Resistance 3 (R3) 3.24 3.12 3.12
    Resistance 2 (R2) 3.12 2.99 3.10 3.09
    Resistance 1 (R1) 2.91 2.91 2.85 2.88 3.07
    Pivot Point 2.79 2.79 2.76 2.77 2.79
    Support 1 (S1) 2.58 2.66 2.52 2.55 2.35
    Support 2 (S2) 2.46 2.58 2.44 2.33
    Support 3 (S3) 2.25 2.46 2.30
    Support 4 (S4) 2.22